DBOCX | VBINX | DBOCX / VBINX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 21 years | 32 years | - |
Gain YTD | 2.867 | 2.021 | 142% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 289M | 57.5B | 1% |
Annual Yield % from dividends | 0.48 | 1.88 | 26% |
Returns for 1 year | 8.57 | 11.65 | 74% |
Returns for 3 years | 2.11 | 9.15 | 23% |
Returns for 5 years | 4.59 | 31.13 | 15% |
Returns for 10 years | 16.60 | 83.75 | 20% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNSX | 68.48 | 0.79 | +1.17% |
Janus Henderson Global Life Sciences S | |||
LMRIX | 30.71 | N/A | N/A |
1919 Financial Services I | |||
SMAPX | 10.80 | N/A | N/A |
Westwood Salient MLP & Engy Infras A | |||
WPOIX | 12.29 | N/A | N/A |
Weitz Partners III Opportunity Investor | |||
LAFGX | 14.36 | N/A | N/A |
Lord Abbett International Growth F |